Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$31.82 – $105.60
14% from low
Exchange
OTC Link
ADRC
Borrow rate
5.22%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.35B | $1.45B | $1.35B | $1.49B | $1.64B | $1.96B | $2.24B | $2.34B |
| Cost of revenue | $361.2M | $351.1M | $344.4M | $410.2M | $411.0M | $488.0M | $562.1M | $615.2M |
| Gross profit | $990.2M | $1.09B | $1.01B | $1.08B | $1.23B | $1.47B | $1.67B | $1.73B |
| Gross margin | 73.3% | 75.7% | 74.5% | 72.5% | 75.0% | 75.0% | 74.9% | 73.7% |
| R&D | $167.7M | $184.4M | $185.1M | $195.0M | $210.7M | $244.9M | $277.0M | $291.5M |
| Operating income | $328.1M | $364.9M | $259.0M | $327.9M | $361.7M | $412.4M | $475.0M | $406.1M |
| EBITDA | $362.3M | $409.3M | $336.5M | $404.3M | $434.7M | $486.9M | $578.9M | $619.9M |
| Net income | $245.8M | $276.7M | −$238.3M | $326.5M | $289.1M | $300.6M | $356.8M | $388.9M |
| Net margin | 18.2% | 19.1% | -17.6% | 21.9% | 17.6% | 15.4% | 16.0% | 16.6% |
| EPS (diluted) | 2.13 | 2.40 | -2.00 | 2.47 | 2.20 | 2.28 | 2.72 | 2.97 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.5B | $2.41 | $2.35–$2.53 | 1 |
| 2027 | $2.6B | $2.71 | $2.64–$2.84 | 1 |
Forward consensus · source: Financial Modeling Prep
COCHLEAR PLC UNSP/ADR
No one on the platform currently holds CHEOY.
No tracked institution reports a position in CHEOY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-20 | $0.7596 | 2026-04-28 |
| 2025-09-19 | $0.6913 | 2025-10-28 |
| 2025-03-21 | $0.6783 | 2025-04-29 |
| 2024-09-18 | $0.7037 | 2024-10-25 |
| 2024-03-21 | $0.6469 | 2024-04-30 |
| 2023-09-15 | $0.5602 | 2023-10-26 |
No one on the platform has traded CHEOY yet.
| +0.58% |
| $13.3B |
| — |
| FSPKFFisher & Paykel Healthcare Corporation Limited | $22.52 | +0.00% | $13.2B | — |
| SONVFSonova Holding AG | $235.45 | +2.81% | $14.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 9.0× earnings vs its 33.2× historical median P/E.
Fair value ≈ $154.61 · price $42.15 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.